These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 14557478

  • 1. Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease.
    Kretowski A, Wawrusiewicz N, Mironczuk K, Mysliwiec J, Kretowska M, Kinalska I.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4945-9. PubMed ID: 14557478
    [Abstract] [Full Text] [Related]

  • 2. Intercellular adhesion molecule 1 gene polymorphisms do not contribute to Graves' disease in Chinese patients.
    Wang S, Sun H, Chen HY, Zhao ZF, Yang Y, Zhao YJ, Cui B, Ning G.
    Endocrine; 2007 Apr; 31(2):114-8. PubMed ID: 17873320
    [Abstract] [Full Text] [Related]

  • 3. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF, Develi-İş S, Doğru-Abbasoğlu S, Vural P, Ozderya A, Karadağ B, Uysal M.
    Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
    [Abstract] [Full Text] [Related]

  • 4. ICAM1 K469E and E-selectin S128R polymorphisms could predispose to increased autoantibody production and TSH suppression in Graves' disease.
    Kanmaz-Özer M, Doğru-Abbasoğlu S, Vural P, Özderya A, Karadağ B, Uysal M.
    Mol Biol Rep; 2013 Mar; 40(3):2717-22. PubMed ID: 23242661
    [Abstract] [Full Text] [Related]

  • 5. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
    De Bellis A, Bizzarro A, Gattoni A, Romano C, Di Martino S, Sinisi AA, Abbadessa S, Bellastella A.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
    [Abstract] [Full Text] [Related]

  • 6. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R.
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease.
    Vural P, Baki M, Doğru-Abbasoğlu S, Özderya A, Karadağ B, Uysal M.
    Int Immunopharmacol; 2012 Oct; 14(2):133-7. PubMed ID: 22771446
    [Abstract] [Full Text] [Related]

  • 8. Association study of endometriosis and intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in a Japanese population.
    Yamashita M, Yoshida S, Kennedy S, Ohara N, Motoyama S, Maruo T.
    J Soc Gynecol Investig; 2005 May; 12(4):267-71. PubMed ID: 15866119
    [Abstract] [Full Text] [Related]

  • 9. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy.
    De Bellis A, Di Martino S, Fiordelisi F, Muccitelli VI, Sinisi AA, Abbate GF, Gargano D, Bellastella A, Bizzarro A.
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1222-5. PubMed ID: 9543145
    [Abstract] [Full Text] [Related]

  • 10. Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.
    Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, Shimajiri Y, Yabiku K, Yoshimura H.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2593-6. PubMed ID: 12050220
    [Abstract] [Full Text] [Related]

  • 11. Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease.
    Gu XJ, Cui B, Zhao ZF, Chen HY, Li XY, Wang S, Ning G, Zhao YJ.
    Clin Immunol; 2008 Jun; 127(3):298-302. PubMed ID: 18394967
    [Abstract] [Full Text] [Related]

  • 12. Association between interleukin 21 and Graves' disease.
    Jia HY, Zhang ZG, Gu XJ, Guo T, Cui B, Ning G, Zhao YJ.
    Genet Mol Res; 2011 Oct 31; 10(4):3338-46. PubMed ID: 22057994
    [Abstract] [Full Text] [Related]

  • 13. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
    Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K.
    Clin Endocrinol (Oxf); 2000 Jun 31; 52(6):759-64. PubMed ID: 10848881
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism.
    Namo Cury A, Longui CA, Kochi C, Calliari LE, Scalissi N, Salles JE, Neves Rocha M, Barbosa de Melo M, Rezende Melo M, Monte O.
    Horm Res; 2008 Jun 31; 70(1):36-41. PubMed ID: 18493148
    [Abstract] [Full Text] [Related]

  • 16. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q, Yang YM, Lv XY.
    J Zhejiang Univ Sci B; 2006 Nov 31; 7(11):887-91. PubMed ID: 17048303
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.
    Jazdzewski K, Bednarczuk T, Stepnowska M, Liyanarachchi S, Suchecka-Rachon K, Limon J, Narkiewicz K.
    Int J Mol Med; 2007 Jan 31; 19(1):181-6. PubMed ID: 17143563
    [Abstract] [Full Text] [Related]

  • 19. Intercellular adhesion molecule-1 (ICAM-1) in the sera of patients with Graves' disease: correlation with disease activity and treatment status.
    Fukazawa H, Yoshida K, Kaise N, Kiso Y, Sayama N, Mori K, Kikuchi K, Aizawa Y, Rikimaru A, Abe K.
    Thyroid; 1995 Oct 31; 5(5):373-7. PubMed ID: 8563475
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.